TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs3101942
log Bayes Factor = 137.833
Chromosome 6   position 32,870,057  (GRCh37) Explore rs3101942 on Ensembl!
Variant rs3101942 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
E10.9 Without complications
0.000 0.000 1.000
E10.3 With ophthalmic complications
0.000 0.000 1.000
E10.1 With ketoacidosis
0.000 0.000 1.000
J45.9 Asthma, unspecified
0.000 0.000 1.000
K90.0 Coeliac disease
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
E16.2 Hypoglycaemia, unspecified
0.000 0.000 1.000
E16 Other disorders of pancreatic internal secretion
0.000 0.000 1.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.000 1.000
E10.4 With neurological complications
0.000 0.000 1.000
L40.9 Psoriasis, unspecified
0.999 0.001 0.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.001 0.999
L40.5 Arthropathic psoriasis
0.996 0.004 0.000
L40 Psoriasis
0.996 0.004 0.000
E14 Unspecified diabetes mellitus
0.000 0.005 0.995
E14.3 With ophthalmic complications
0.000 0.010 0.990
E05.9 Thyrotoxicosis, unspecified
0.000 0.011 0.989
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.012 0.988
G35 Multiple sclerosis
0.986 0.014 0.000
E10.2 With renal complications
0.000 0.022 0.978
E10.8 With unspecified complications
0.000 0.022 0.978
E10.0 With coma
0.000 0.042 0.958
E10.5 With peripheral circulatory complications
0.000 0.060 0.940
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.110 0.890
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.137 0.863
E10.6 With other specified complications
0.000 0.159 0.841
E40-E46 Malnutrition
0.000 0.164 0.836
E03.8 Other specified hypothyroidism
0.000 0.168 0.832
E06 Thyroiditis
0.000 0.170 0.830
E14.8 With unspecified complications
0.000 0.186 0.814
L40.1 Generalised pustular psoriasis
0.811 0.189 0.000
E14.5 With peripheral circulatory complications
0.000 0.237 0.763
E13 Other specified diabetes mellitus
0.000 0.238 0.762
E14.6 With other specified complications
0.000 0.243 0.757
K90 Intestinal malabsorption
0.000 0.252 0.748
E14.1 With ketoacidosis
0.000 0.255 0.744
L40.4 Guttate psoriasis
0.737 0.263 0.000
L40.8 Other psoriasis
0.730 0.269 0.000
E46 Unspecified protein-energy malnutrition
0.000 0.281 0.719
E10.7 With multiple complications
0.000 0.283 0.717
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.283 0.717
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.283 0.717
E16.4 Abnormal secretion of gastrin
0.000 0.283 0.717
E16.3 Increased secretion of glucagon
0.000 0.283 0.717
E15 Nondiabetic hypoglycaemic coma
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.284 0.716
E05.4 Thyrotoxicosis factitia
0.000 0.284 0.716
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.284 0.716
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.284 0.716
L40.2 Acrodermatitis continua
0.714 0.286 0.000
E14.7 With multiple complications
0.000 0.287 0.713
E14.0 With coma
0.000 0.287 0.713
E14.2 Withrenal complications
0.000 0.307 0.693
E16.1 Other hypoglycaemia
0.000 0.310 0.690
E06.3 Autoimmune thyroiditis
0.000 0.310 0.690
E03.1 Congenital hypothyroidism without goitre
0.000 0.312 0.688
E14.4 With neurological complications
0.000 0.322 0.678
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.330 0.670
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.350 0.650
L40.3 Pustulosis palmaris et plantaris
0.630 0.369 0.000
K90.9 Intestinal malabsorption, unspecified
0.000 0.372 0.628
E06.9 Thyroiditis, unspecified
0.000 0.387 0.613
E06.1 Subacute thyroiditis
0.000 0.389 0.611
E05.8 Other thyrotoxicosis
0.000 0.396 0.604
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.400 0.600
E45 Retarded development following protein-energy malnutrition
0.000 0.400 0.600
E43 Unspecified severe protein-energy malnutrition
0.000 0.400 0.600
E42 Marasmic kwashiorkor
0.000 0.400 0.600
E41 Nutritional marasmus
0.000 0.400 0.600
E40 Kwashiorkor
0.000 0.400 0.600
E06.4 Drug-induced thyroiditis
0.000 0.405 0.595
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.405 0.595
E06.0 Acute thyroiditis
0.000 0.405 0.595
E06.5 Other chronic thyroiditis
0.000 0.406 0.594
E14.9 Without complications
0.000 0.406 0.594
E13.9 Without complications
0.000 0.413 0.587
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.431 0.568
E20-E35 Disorders of other endocrine glands
0.000 0.439 0.561
E13.3 With ophthalmic complications
0.000 0.448 0.552
E13.8 With unspecified complications
0.000 0.454 0.546
E13.7 With multiple complications
0.000 0.454 0.546
E13.6 With other specified complications
0.000 0.454 0.546
E13.5 With peripheral circulatory complications
0.000 0.454 0.546
E13.4 With neurological complications
0.000 0.454 0.546
E13.2 With renal complications
0.000 0.454 0.546
E13.1 With ketoacidosis
0.000 0.454 0.546
E13.0 With coma
0.000 0.454 0.546
E11 Non-insulin-dependent diabetes mellitus
0.000 0.456 0.544
K90.3 Pancreatic steatorrhoea
0.000 0.463 0.537
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.463 0.537
K90.1 Tropical sprue
0.000 0.463 0.537
K90.8 Other intestinal malabsorption
0.000 0.471 0.529
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
E11.2 With renal complications
0.000 0.494 0.506
E24 Cushing's syndrome
0.000 0.509 0.491
E07 Other disorders of thyroid
0.000 0.516 0.484
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.547 0.453
E11.5 With peripheral circulatory complications
0.000 0.550 0.450
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.000 0.560 0.439
E22 Hyperfunction of pituitary gland
0.000 0.563 0.437
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.436 0.564 0.000
E50-E64 Other nutritional deficiencies
0.003 0.566 0.430
E44.1 Mild protein-energy malnutrition
0.000 0.570 0.430
E44.0 Moderate protein-energy malnutrition
0.000 0.570 0.430
E11.1 With ketoacidosis
0.000 0.570 0.430
E11.6 With other specified complications
0.000 0.593 0.407
E29 Testicular dysfunction
0.000 0.595 0.405
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.597 0.402
E32 Diseases of thymus
0.000 0.597 0.402
E30 Disorders of puberty, not elsewhere classified
0.000 0.597 0.402
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.402 0.598 0.000
E24.2 Drug-induced Cushing's syndrome
0.000 0.601 0.399
E23 Hypofunction and other disorders of pituitary gland
0.000 0.606 0.394
E24.0 Pituitary-dependent Cushing's disease
0.000 0.608 0.392
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.610 0.390
E11.7 With multiple complications
0.000 0.610 0.390
E26 Hyperaldosteronism
0.000 0.611 0.389
E28 Ovarian dysfunction
0.000 0.613 0.387
E25 Adrenogenital disorders
0.000 0.615 0.385
E61 Deficiency of other nutrient elements
0.002 0.617 0.381
E24.9 Cushing's syndrome, unspecified
0.000 0.618 0.382
E22.1 Hyperprolactinaemia
0.000 0.627 0.373
E20 Hypoparathyroidism
0.000 0.636 0.364
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.641 0.359
E31 Polyglandular dysfunction
0.000 0.643 0.356
E61.1 Iron deficiency
0.000 0.646 0.354
E24.8 Other Cushing's syndrome
0.000 0.648 0.352
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.648 0.352
E24.3 Ectopic ACTH syndrome
0.000 0.648 0.352
E24.1 Nelson's syndrome
0.000 0.648 0.352
L40.0 Psoriasis vulgaris
0.347 0.652 0.001
E07.1 Dyshormogenetic goitre
0.000 0.653 0.347
E07.0 Hypersecretion of calcitonin
0.000 0.653 0.347
E23.2 Diabetes insipidus
0.000 0.653 0.347
E34 Other endocrine disorders
0.000 0.655 0.345
E21.2 Other hyperparathyroidism
0.000 0.660 0.340
T42.4 Benzodiazepines
0.338 0.662 0.000
J45 Asthma
0.000 0.662 0.338
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.338 0.662 0.000
T42.0 Hydantoin derivatives
0.332 0.668 0.000
E21.4 Other specified disorders of parathyroid gland
0.000 0.675 0.325
E11.8 With unspecified complications
0.000 0.675 0.325
E28.3 Primary ovarian failure
0.000 0.677 0.323
E21.3 Hyperparathyroidism, unspecified
0.000 0.678 0.322
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.684 0.316
E22.8 Other hyperfunction of pituitary gland
0.000 0.686 0.314
E64 Sequelae of malnutrition and other nutritional deficiencies
0.003 0.689 0.309
E50 Vitamin A deficiency
0.003 0.689 0.309
E60 Dietary zinc deficiency
0.003 0.689 0.309
E59 Dietary selenium deficiency
0.003 0.689 0.309
E54 Ascorbic acid deficiency
0.003 0.689 0.309
E52 Niacin deficiency [pellagra]
0.003 0.689 0.309
E07.8 Other specified disorders of thyroid
0.000 0.689 0.311
E51 Thiamine deficiency
0.002 0.696 0.302
E11.0 With coma
0.000 0.700 0.300
T42.1 Iminostilbenes
0.299 0.701 0.000
E63 Other nutritional deficiencies
0.003 0.703 0.295
T36-T50 Poisoning by drugs, medicaments and biological substances
0.294 0.706 0.000
E29.1 Testicular hypofunction
0.000 0.707 0.293
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.708 0.292
E23.7 Disorder of pituitary gland, unspecified
0.000 0.708 0.292
E29.9 Testicular dysfunction, unspecified
0.000 0.709 0.290
E29.8 Other testicular dysfunction
0.000 0.709 0.290
E29.0 Testicular hyperfunction
0.000 0.709 0.290
E22.0 Acromegaly and pituitary gigantism
0.000 0.711 0.289
E30.9 Disorder of puberty, unspecified
0.000 0.711 0.289
E30.8 Other disorders of puberty
0.000 0.711 0.289
E30.1 Precocious puberty
0.000 0.711 0.289
E30.0 Delayed puberty
0.000 0.711 0.289
E32.9 Disease of thymus, unspecified
0.000 0.711 0.289
E32.8 Other diseases of thymus
0.000 0.711 0.289
E32.1 Abscess of thymus
0.000 0.711 0.289
E32.0 Persistent hyperplasia of thymus
0.000 0.711 0.289
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.711 0.289
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.711 0.289
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.711 0.289
T42.5 Mixed antiepileptics, not elsewhere classified
0.288 0.711 0.000
T42.3 Barbiturates
0.288 0.711 0.000
T42.2 Succinimides and oxazolidinediones
0.288 0.711 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.717 0.283
E23.1 Drug-induced hypopituitarism
0.000 0.717 0.283
H36.0 Diabetic retinopathy
0.000 0.720 0.280
E26.8 Other hyperaldosteronism
0.000 0.721 0.279
E26.1 Secondary hyperaldosteronism
0.000 0.721 0.279
L40-L45 Papulosquamous disorders
0.278 0.722 0.000
E28.9 Ovarian dysfunction, unspecified
0.000 0.722 0.278
E28.8 Other ovarian dysfunction
0.000 0.722 0.278
E28.1 Androgen excess
0.000 0.722 0.278
E28.0 Oestrogen excess
0.000 0.722 0.278
E56 Other vitamin deficiencies
0.003 0.722 0.275
G35-G37 Demyelinating diseases of the central nervous system
0.277 0.723 0.000
E25.9 Adrenogenital disorder, unspecified
0.000 0.723 0.276
E25.8 Other adrenogenital disorders
0.000 0.723 0.276
E26.0 Primary hyperaldosteronism
0.000 0.725 0.275
E61.9 Deficiency of nutrient element, unspecified
0.001 0.725 0.273
E61.8 Deficiency of other specified nutrient elements
0.001 0.725 0.273
E61.7 Deficiency of multiple nutrient elements
0.001 0.725 0.273
E61.6 Vanadium deficiency
0.001 0.725 0.273
E61.5 Molybdenum deficiency
0.001 0.725 0.273
E61.4 Chromium deficiency
0.001 0.725 0.273
E61.3 Manganese deficiency
0.001 0.725 0.273
E61.0 Copper deficiency
0.001 0.725 0.273
E26.9 Hyperaldosteronism, unspecified
0.000 0.730 0.270
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.269 0.731 0.000
E23.6 Other disorders of pituitary gland
0.000 0.733 0.267
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.262 0.738 0.000
E20.8 Other hypoparathyroidism
0.000 0.739 0.261
E20.1 Pseudohypoparathyroidism
0.000 0.739 0.261
E20.0 Idiopathic hypoparathyroidism
0.000 0.739 0.261
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.260 0.740 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.741 0.259
E65-E68 Obesity and other hyperalimentation
0.000 0.742 0.257
E34.3 Short stature, not elsewhere classified
0.000 0.744 0.256
E31.9 Polyglandular dysfunction, unspecified
0.000 0.744 0.256
E31.8 Other polyglandular dysfunction
0.000 0.744 0.256
E31.1 Polyglandular hyperfunction
0.000 0.744 0.256
E58 Dietary calcium deficiency
0.003 0.747 0.250
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.248 0.752 0.000
E34.8 Other specified endocrine disorders
0.000 0.752 0.248
E34.5 Androgen resistance syndrome
0.000 0.753 0.247
E34.4 Constitutional tall stature
0.000 0.753 0.247
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.753 0.247
E34.1 Other hypersecretion of intestinal hormones
0.000 0.753 0.247
E61.2 Magnesium deficiency
0.001 0.755 0.243
T47.1 Other antacids and anti-gastric-secretion drugs
0.240 0.760 0.000
E34.0 Carcinoid syndrome
0.000 0.761 0.239
J45.0 Predominantly allergic asthma
0.000 0.761 0.239
N08.3 Glomerular disorders in diabetes mellitus
0.000 0.763 0.237
E11.3 With ophthalmic complications
0.000 0.767 0.233
T45.0 Antiallergic and antiemetic drugs
0.232 0.768 0.000
N08 Glomerular disorders in diseases classified elsewhere
0.000 0.770 0.230
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.229 0.771 0.000
J45.1 Nonallergic asthma
0.000 0.772 0.228
T50.9 Other and unspecified drugs, medicaments and biological substances
0.228 0.772 0.000
N00-N08 Glomerular diseases
0.000 0.772 0.228
N04 Nephrotic syndrome
0.000 0.773 0.227
N05 Unspecified nephritic syndrome
0.000 0.775 0.225
E50.9 Vitamin A deficiency, unspecified
0.002 0.777 0.221
E50.8 Other manifestations of vitamin A deficiency
0.002 0.777 0.221
E50.7 Other ocular manifestations of vitamin A deficiency
0.002 0.777 0.221
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.002 0.777 0.221
E50.5 Vitamin A deficiency with night blindness
0.002 0.777 0.221
E50.4 Vitamin A deficiency with keratomalacia
0.002 0.777 0.221
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.002 0.777 0.221
E50.2 Vitamin A deficiency with corneal xerosis
0.002 0.777 0.221
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.002 0.777 0.221
E50.0 Vitamin A deficiency with conjunctival xerosis
0.002 0.777 0.221
E64.9 Sequelae of unspecified nutritional deficiency
0.002 0.777 0.221
E64.8 Sequelae of other nutritional deficiencies
0.002 0.777 0.221
E64.3 Sequelae of rickets
0.002 0.777 0.221
E64.2 Sequelae of vitamin C deficiency
0.002 0.777 0.221
E64.1 Sequelae of vitamin A deficiency
0.002 0.777 0.221
E64.0 Sequelae of protein-energy malnutrition
0.002 0.777 0.221
E20.9 Hypoparathyroidism, unspecified
0.000 0.777 0.223
N04.9 Unspecified
0.000 0.778 0.222
E11.9 Without complications
0.000 0.778 0.222
E51.9 Thiamine deficiency, unspecified
0.002 0.782 0.217
E51.8 Other manifestations of thiamine deficiency
0.002 0.782 0.217
E51.1 Beriberi
0.002 0.782 0.217
N05.9 Unspecified
0.000 0.784 0.216
E21.0 Primary hyperparathyroidism
0.000 0.785 0.215
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.215 0.785 0.000
E63.8 Other specified nutritional deficiencies
0.002 0.787 0.211
E63.1 Imbalance of constituents of food intake
0.002 0.787 0.211
E63.0 Essential fatty acid [EFA] deficiency
0.002 0.787 0.211
T47.0 Histamine H(2)-receptor antagonists
0.212 0.788 0.000
E51.2 Wernicke's encephalopathy
0.002 0.788 0.210
J45.8 Mixed asthma
0.000 0.788 0.211
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.211 0.789 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.211 0.789 0.000
T50.8 Diagnostic agents
0.210 0.790 0.000
E31.0 Autoimmune polyglandular failure
0.000 0.790 0.210
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.209 0.791 0.000
E53 Deficiency of other B group vitamins
0.002 0.793 0.206
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.206 0.794 0.000
T36 Poisoning by systemic antibiotics
0.204 0.795 0.000
L42 Pityriasis rosea
0.204 0.795 0.000
T47.2 Stimulant laxatives
0.204 0.796 0.000
M07.39 Other psoriatic arthropathies (Site unspecified)
0.204 0.796 0.000
T45.4 Iron and its compounds
0.203 0.797 0.000
M07.3 Other psoriatic arthropathies
0.203 0.797 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.200 0.800 0.000
L44 Other papulosquamous disorders
0.200 0.800 0.000
L41 Parapsoriasis
0.200 0.800 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.200 0.800 0.000
E63.9 Nutritional deficiency, unspecified
0.002 0.801 0.197
E56.9 Vitamin deficiency, unspecified
0.002 0.801 0.197
E56.8 Deficiency of other vitamins
0.002 0.801 0.197
E56.0 Deficiency of vitamin E
0.002 0.801 0.197
E11.4 With neurological complications
0.000 0.803 0.197
E55 Vitamin D deficiency
0.009 0.807 0.184
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.193 0.807 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.193 0.807 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.193 0.807 0.000
T47.7 Emetics
0.193 0.807 0.000
T47.6 Antidiarrhoeal drugs
0.193 0.807 0.000
T47.5 Digestants
0.193 0.807 0.000
T47.4 Other laxatives
0.193 0.807 0.000
T47.3 Saline and osmotic laxatives
0.193 0.807 0.000
E07.9 Disorder of thyroid, unspecified
0.000 0.809 0.190
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.190 0.810 0.000
N04.1 Focal and segmental glomerular lesions
0.000 0.811 0.189
N04.2 Diffuse membranous glomerulonephritis
0.000 0.811 0.189
N05.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.812 0.188
N05.1 Focal and segmental glomerular lesions
0.000 0.812 0.188
T43.5 Other and unspecified antipsychotics and neuroleptics
0.188 0.812 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.187 0.812 0.000
T45.2 Vitamins, not elsewhere classified
0.187 0.813 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.186 0.814 0.000
T50.7 Analeptics and opioid receptor antagonists
0.186 0.814 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.186 0.814 0.000
T50.5 Appetite depressants
0.186 0.814 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.186 0.814 0.000
T50.1 Loop [high-ceiling] diuretics
0.186 0.814 0.000
T50.0 Mineralocorticoids and their antagonists
0.186 0.814 0.000
E34.9 Endocrine disorder, unspecified
0.000 0.814 0.186
E67 Other hyperalimentation
0.000 0.815 0.184
E68 Sequelae of hyperalimentation
0.000 0.815 0.184
T46 Poisoning by agents primarily affecting the cardiovascular system
0.184 0.816 0.000
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.184 0.816 0.000
T38.1 Thyroid hormones and substitutes
0.183 0.817 0.000
G36 Other acute disseminated demyelination
0.183 0.817 0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases
0.000 0.821 0.179
T45.9 Primarily systemic and haematological agent, unspecified
0.178 0.822 0.000
T45.8 Other primarily systemic and haematological agents
0.178 0.822 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.178 0.822 0.000
T45.6 Fibrinolysis-affecting drugs
0.178 0.822 0.000
T45.3 Enzymes, not elsewhere classified
0.178 0.822 0.000
E28.2 Polycystic ovarian syndrome
0.000 0.824 0.176
T50.4 Drugs affecting uric acid metabolism
0.175 0.825 0.000
N05.2 Diffuse membranous glomerulonephritis
0.000 0.826 0.174
M07.34 Other psoriatic arthropathies (Hand)
0.171 0.829 0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.170 0.829 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.168 0.832 0.000
N05.7 Diffuse crescentic glomerulonephritis
0.000 0.834 0.166
E56.1 Deficiency of vitamin K
0.002 0.834 0.163
N08.8 Glomerular disorders in other diseases classified elsewhere
0.000 0.835 0.165
N08.1 Glomerular disorders in neoplastic diseases
0.000 0.835 0.165
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere
0.000 0.835 0.165
T39.4 Antirheumatics, not elsewhere classified
0.165 0.835 0.000
T39.2 Pyrazolone derivatives
0.165 0.835 0.000
T39.0 Salicylates
0.164 0.836 0.000
N07 Hereditary nephropathy, not elsewhere classified
0.000 0.837 0.163
N06 Isolated proteinuria with specified morphological lesion
0.000 0.837 0.163
N01 Rapidly progressive nephritic syndrome
0.000 0.837 0.163
N00 Acute nephritic syndrome
0.000 0.837 0.163
N04.8 Other
0.000 0.837 0.163
N04.7 Diffuse crescentic glomerulonephritis
0.000 0.837 0.163
N04.6 Dense deposit disease
0.000 0.837 0.163
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.000 0.837 0.163
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.837 0.163
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.837 0.163
N05.6 Dense deposit disease
0.000 0.838 0.161
N05.4 Diffuse endocapillary proliferative glomerulonephritis
0.000 0.838 0.161
N05.0 Minor glomerular abnormality
0.000 0.838 0.161
T43.9 Psychotropic drug, unspecified
0.161 0.839 0.000
T38.0 Glucocorticoids and synthetic analogues
0.161 0.839 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.161 0.839 0.000
N05.3 Diffuse mesangial proliferative glomerulonephritis
0.000 0.840 0.160
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.159 0.841 0.000
T43.2 Other and unspecified antidepressants
0.159 0.841 0.000
T39.1 4-Aminophenol derivatives
0.159 0.841 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.158 0.842 0.000
M07.38 Other psoriatic arthropathies (Other)
0.157 0.842 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.157 0.843 0.000
G37 Other demyelinating diseases of central nervous system
0.156 0.844 0.000
T38.9 Other and unspecified hormone antagonists
0.154 0.846 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.154 0.846 0.000
T38.7 Androgens and anabolic congeners
0.154 0.846 0.000
T38.5 Other oestrogens and progestogens
0.154 0.846 0.000
T38.4 Oral contraceptives
0.154 0.846 0.000
T38.2 Antithyroid drugs
0.154 0.846 0.000
T41.5 Therapeutic gases
0.151 0.849 0.000
T41.4 Anaesthetic, unspecified
0.151 0.849 0.000
T41.3 Local anaesthetics
0.151 0.849 0.000
T41.2 Other and unspecified general anaesthetics
0.151 0.849 0.000
T41.1 Intravenous anaesthetics
0.151 0.849 0.000
T41.0 Inhaled anaesthetics
0.151 0.849 0.000
T49.9 Topical agent, unspecified
0.151 0.849 0.000
T49.8 Other topical agents
0.151 0.849 0.000
T49.7 Dental drugs, topically applied
0.151 0.849 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.151 0.849 0.000
T49.5 Ophthalmological drugs and preparations
0.151 0.849 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.151 0.849 0.000
T49.3 Emollients, demulcents and protectants
0.151 0.849 0.000
T49.2 Local astringents and local detergents
0.151 0.849 0.000
T49.1 Antipruritics
0.151 0.849 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.151 0.849 0.000
N04.0 Minor glomerular abnormality
0.000 0.849 0.150
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.150 0.850 0.000
T37.5 Antiviral drugs
0.150 0.850 0.000
T37.4 Anthelminthics
0.150 0.850 0.000
T37.3 Other antiprotozoal drugs
0.150 0.850 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.150 0.850 0.000
T37.1 Antimycobacterial drugs
0.150 0.850 0.000
T37.0 Sulphonamides
0.150 0.850 0.000
E53.1 Pyridoxine deficiency
0.001 0.851 0.148
E53.0 Riboflavin deficiency
0.001 0.851 0.148
T37.8 Other specified systemic anti-infectives and antiparasitics
0.148 0.851 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.148 0.852 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.148 0.852 0.000
T36.9 Systemic antibiotic, unspecified
0.147 0.853 0.000
T36.8 Other systemic antibiotics
0.147 0.853 0.000
T36.7 Antifungal antibiotics, systemically used
0.147 0.853 0.000
T36.6 Rifamycins
0.147 0.853 0.000
T36.5 Aminoglycosides
0.147 0.853 0.000
T36.4 Tetracyclines
0.147 0.853 0.000
T36.3 Macrolides
0.147 0.853 0.000
T36.2 Chloramphenicol group
0.147 0.853 0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism
0.000 0.853 0.146
M07.33 Other psoriatic arthropathies (Forearm)
0.146 0.854 0.000
M07.32 Other psoriatic arthropathies (Upper arm)
0.146 0.854 0.000
L41.9 Parapsoriasis, unspecified
0.143 0.856 0.000
L41.8 Other parapsoriasis
0.143 0.856 0.000
L41.5 Retiform parapsoriasis
0.143 0.856 0.000
L41.4 Large plaque parapsoriasis
0.143 0.856 0.000
L41.3 Small plaque parapsoriasis
0.143 0.856 0.000
L41.2 Lymphomatoid papulosis
0.143 0.856 0.000
L41.1 Pityriasis lichenoides chronica
0.143 0.856 0.000
L41.0 Pityriasis lichenoides et varioliformis acuta
0.143 0.856 0.000
L44.9 Papulosquamous disorder, unspecified
0.143 0.856 0.000
L44.8 Other specified papulosquamous disorders
0.143 0.856 0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.143 0.856 0.000
L44.3 Lichen ruber moniliformis
0.143 0.856 0.000
L44.2 Lichen striatus
0.143 0.856 0.000
L44.1 Lichen nitidus
0.143 0.856 0.000
L44.0 Pityriasis rubra pilaris
0.143 0.856 0.000
M07.36 Other psoriatic arthropathies (Lower leg)
0.142 0.857 0.000
N05.8 Other
0.000 0.858 0.142
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.141 0.859 0.000
E53.9 Vitamin B deficiency, unspecified
0.001 0.859 0.140
T46.3 Coronary vasodilators, not elsewhere classified
0.141 0.859 0.000
N08.5 Glomerular disorders in systemic connective tissue disorders
0.000 0.860 0.140
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.139 0.860 0.000
E55.0 Rickets, active
0.007 0.861 0.132
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.138 0.861 0.000
T48.5 Anti-common-cold drugs
0.138 0.861 0.000
T48.4 Expectorants
0.138 0.861 0.000
T48.3 Antitussives
0.138 0.861 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.138 0.861 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.138 0.861 0.000
T48.0 Oxytocic drugs
0.138 0.861 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.137 0.862 0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.137 0.863 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.137 0.863 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.137 0.863 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.137 0.863 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.137 0.863 0.000
T44.0 Anticholinesterase agents
0.137 0.863 0.000
M07.31 Other psoriatic arthropathies (Shoulder region)
0.136 0.864 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.135 0.865 0.000
T43.3 Phenothiazine antipsychotics and neuroleptics
0.135 0.865 0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.134 0.866 0.000
E67.8 Other specified hyperalimentation
0.000 0.867 0.132
E67.3 Hypervitaminosis D
0.000 0.867 0.132
E67.2 Megavitamin-B6 syndrome
0.000 0.867 0.132
E67.1 Hypercarotenaemia
0.000 0.867 0.132
E67.0 Hypervitaminosis A
0.000 0.867 0.132
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.132 0.867 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.132 0.867 0.000
T46.7 Peripheral vasodilators
0.132 0.867 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.132 0.867 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.132 0.867 0.000
G36.9 Acute disseminated demyelination, unspecified
0.131 0.869 0.000
G36.8 Other specified acute disseminated demyelination
0.131 0.869 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.131 0.869 0.000
C56 Malignant neoplasm of ovary
0.000 0.869 0.131
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.130 0.870 0.000
G37.8 Other specified demyelinating diseases of central nervous system
0.129 0.871 0.000
T46.1 Calcium-channel blockers
0.126 0.873 0.000
T36.0 Penicillins
0.126 0.874 0.000
E23.0 Hypopituitarism
0.000 0.875 0.125

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.